Diagnostic performance of Fluorine-18-Fluorodeoxyglucose positron emission tomography in patients with chronic inflammatory bowel disease: A systematic review and a meta-analysis

Journal of Crohn's and Colitis

Volumn 7, Issue 5, 2013, Pages 345-354

  Treglia, Giorgio ^a   Quartuccio, Natale ^b   Sadeghi, Ramin ^c   Farchione, Alessandra ^d   Caldarella, Carmelo ^a   Bertagna, Francesco ^e   Fania, Piercarlo ^f   Cistaro, Angelina ^f  

^a CATHOLIC UNIVERSITY   (Italy)

^b UNIVERSITY OF MESSINA   (Italy)

^c MASHHAD UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^d Istituto di Radiologia di Universita Cattolica del Sacro Cuore di Roma   (Italy)

^e UNIVERSITY OF BRESCIA   (Italy)

^f Positron Emission Tomography Center IRMET SpA   (Italy)

Author keywords

18F FDG; Crohn's disease; Inflammatory bowel disease; PET CT; Positron emission tomography; Ulcerative colitis

Indexed keywords

ENEMA; FLUORODEOXYGLUCOSE F 18;

AREA UNDER THE CURVE; COMPUTER ASSISTED TOMOGRAPHY; CROHN DISEASE; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; ENDOSCOPY; ENTERITIS; HUMAN; IMMUNOSCINTIGRAPHY; MAJOR CLINICAL STUDY; META ANALYSIS; NUCLEAR MAGNETIC RESONANCE IMAGING; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; QUALITATIVE ANALYSIS; REVIEW; SENSITIVITY AND SPECIFICITY; SYSTEMATIC REVIEW; ULCERATIVE COLITIS; ULTRASOUND;

AREA UNDER CURVE; CHRONIC DISEASE; CONFIDENCE INTERVALS; FLUORODEOXYGLUCOSE F18; HUMANS; INFLAMMATORY BOWEL DISEASES; POSITRON-EMISSION TOMOGRAPHY; POSITRON-EMISSION TOMOGRAPHY AND COMPUTED TOMOGRAPHY; RADIOPHARMACEUTICALS; ROC CURVE;

EID: 84875597964     PISSN: 18739946     EISSN: 18764479     Source Type: Journal    
DOI: 10.1016/j.crohns.2012.08.005     Document Type: Review

References (30)

1. Baumgart D.C., Sandborn W.J. Inflammatory bowel disease: clinical aspects and established and evolving therapies. Lancet 2007, 369:1641-1657.
2. Chandler M.B., Zeddun S.M., Borum M.L. The role of positron emission tomography in the evaluation of inflammatory bowel disease. Ann N Y Acad Sci 2011, 1228:59-63.
3. Al-Hawary M., Zimmermann E.M. A new look at Crohn's disease: novel imaging techniques. Curr Opin Gastroenterol 2012, 28:334-340.
4. Treglia G., Cason E., Fagioli G. Recent applications of nuclear medicine in diagnostics (first part). Ital J Med 2010, 4:84-91.
5. Treglia G., Cason E., Fagioli G. Recent applications of nuclear medicine in diagnostics - (second part). Ital J Med 2010, 4:159-166.
6. Prabhakar H.B., Sahani D.V., Fischman A.J., Mueller P.R., Blake M.A. Bowel hot spots at PET-CT. Radiographics 2007, 27:145-159.
7. Treglia G., Calcagni M.L., Rufini V., Leccisotti L., Meduri G.M., Spitilli M.G., et al. Clinical significance of incidental focal colorectal (18)F-fluorodeoxyglucose uptake: our experience and a review of the literature. Colorectal Dis 2012, 14:174-180.
8. Liberati A., Altman D.G., Tetzlaff J., Mulrow C., Gøtzsche P.C., Ioannidis J.P., et al. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration. J Clin Epidemiol 2009, 62:e1-e34.
9. Oxford Center for evidence-based medicine checklist for diagnostic studies appraisal Available at, Accessed July 27th 2012. http://www.cebm.net/index.aspx?o_1025.
10. Zamora J., Abraira V., Muriel A., Khan K., Coomarasamy A. Meta-DiSc: a software for meta-analysis of test accuracy data. BMC Med Res Methodol 2006, 6:31.
11. Bicik I., Bauerfeind P., Breitbach T., von Schulthess G.K., Fried M. Inflammatory bowel disease activity measured by positron-emission tomography. Lancet 1997, 350:262.
12. 18F-fluorodeoxyglucose positron tomography in diagnosis of paediatric inflammatory bowel disease. Lancet 1999, 354:836-837.
13. 18F-fluorodeoxyglucose positron emission tomography, hydromagnetic resonance imaging, and granulocyte scintigraphy with labeled antibodies. Am J Gastroenterol 2002, 97:1978-1985.
14. Lemberg D.A., Issenman R.M., Cawdron R., Green T., Mernagh J., Skehan S.J., et al. Positron emission tomography in the investigation of pediatric inflammatory bowel disease. Inflamm Bowel Dis 2005, 11:733-738.
15. 18F-FDG-PET in pediatric patients with chronic inflammatory bowel disease. Ann N Y Acad Sci 2006, 1072:379-385.
16. Meisner R.S., Spier B.J., Einarsson S., Roberson E.N., Perlman S.B., Bianco J.A., et al. Pilot study using PET/CT as a novel, noninvasive assessment of disease activity in inflammatory bowel disease. Inflamm Bowel Dis 2007, 13:993-1000.
17. Louis E., Ancion G., Colard A., Spote V., Belaiche J., Hustinx R. Noninvasive assessment of Crohn's disease intestinal lesions with (18)F-FDG PET/CT. J Nucl Med 2007, 48:1053-1059.
18. Das C.J., Makharia G., Kumar R., Chawla M., Goswami P., Sharma R., et al. PET-CT enteroclysis: a new technique for evaluation of inflammatory diseases of the intestine. Eur J Nucl Med Mol Imaging 2007, 34:2106-2114.
19. Rubin D.T., Surma B.L., Gavzy S.J., Schnell K.M., Bunnag A.P., Huo D., et al. Positron emission tomography (PET) used to image subclinical inflammation associated with ulcerative colitis (UC) in remission. Inflamm Bowel Dis 2009, 15:750-755.
20. 18F-FDG PET/CT. J Nucl Med 2009, 50:1751-1759.
21. 18F-FDG uptake. J Nucl Med 2010, 51:1009-1014.
22. Spier B.J., Perlman S.B., Jaskowiak C.J., Reichelderfer M. PET/CT in the evaluation of inflammatory bowel disease: studies in patients before and after treatment. Mol Imaging Biol 2010, 12:85-88.
23. Das C.J., Makharia G.K., Kumar R., Kumar R., Tiwari R.P., Sharma R., et al. PET/CT colonography: a novel non-invasive technique for assessment of extent and activity of ulcerative colitis. Eur J Nucl Med Mol Imaging 2010, 37:714-721.
24. Ahmadi A., Li Q., Muller K., Collins D., Valentine J.F., Drane W., et al. Diagnostic value of noninvasive combined fluorine-18 labeled fluoro-2-deoxy-d-glucose positron emission tomography and computed tomography enterography in active Crohn's disease. Inflamm Bowel Dis 2010, 16:974-981.
25. 18F-FDG PET/CT enterography: improving on CT enterography assessment of patients with Crohn disease. J Nucl Med 2010, 51:1841-1848.
26. Lapp R.T., Spier B.J., Perlman S.B., Jaskowiak C.J., Reichelderfer M. Clinical utility of positron emission tomography/computed tomography in inflammatory bowel disease. Mol Imaging Biol 2011, 13:573-576.
27. 18F-fluorodeoxyglucose-positron emission tomography and computed tomography. Eur J Gastroenterol Hepatol 2011, 23:81-89.
28. Lenze F., Wessling J., Bremer J., Ullerich H., Spieker T., Weckesser M., et al. Detection and differentiation of inflammatory versus fibromatous Crohn's disease strictures: Prospective comparison of (18)F-FDG-PET/CT, MR-enteroclysis, and transabdominal ultrasound versus endoscopic/histologic evaluation. Inflamm Bowel Dis Feb 22 2012, 10.1002/ibd.22930.
29. 18F-fluorodeoxyglucose positron-emission tomography (PET) can be used to assess inflammation non-invasively in Crohn's disease. Dig Dis Sci May 9 2012, 10.1007/s10620-012-2190-8.
30. Maccioni F., Patak M.A., Signore A., Laghi A. New frontiers of MRI in Crohn's disease: motility imaging, diffusion-weighted imaging, perfusion MRI, MR spectroscopy, molecular imaging, and hybrid imaging (PET/MRI). Abdom Imaging Jun 29 2012, 10.1007/s00261-012-9890-6.